‘K-FLEX’ won the Best Application Award and the entire championship prize at ‘Surgical Robot Challenge 2018’

‘K-FLEX’, Korea’s first flexible endoscopic surgery robot developed by KAIST Future Medical Robotics Group (Director: Prof. Kwon Dong-soo), won the Best Application Award and the entire championship prize at ‘Surgical Robot Challenge 2018’ hosted by Hamlyn Center, Imperial College London, UK on June 29, Netherlands, Switzerland, and other robots in the surgical robots. K-FLEX will perform precise and agile surgical operations with the aid of two surgical tools, a flexible over-tube, and an ergonomic design that are freely movable in the surgical robot demonstration on Sunday, June 24 It is possible to apply it to actual operation. ‘Surgical Robot Challenge’ is a contest to compete innovative ideas of robot technology applicable to surgery. It is the most prestigious competition among surgical robots. Applicability and ripple effect, Innovation, Design, etc. are based on the standards of robots. This competition is held annually as part of the world-renowned Medical Robotics Society ‘Hamlyn Symposium’. Professor Kwon Dong-soo said, “The winner is recognized as a world-renowned technology of the founding company, and the new starting point of the Korean medical device industry has been a research for 20 years.”

Related Video Link : https://youtu.be/esVZxDgvB-I

//easyendosurgical.com/wp-content/uploads/2019/01/footer_logos.png

주식회사 이지엔도서지컬은 상법 제416조 및 제418조 2항, 4항에 의거, 2021년 8월 10일 개최한 이사회에서 아래와 같이 신주발행을 결의하였기에 이를 공고합니다.

 – 아  래 –

○ 제9차 기명식 상환전환우선주식 발행의 건

1.신주식의 종류와 수: 기명식 상환전환 우선주식 3,047주

1.신주식의 액면가액: 1주당 금500원

1.신주식의 발행가액: 1주당 금 656,465원

1.신주식의 배정(인수)방법: 정관 제10조.2항.10호 제3자 배정, 첨부1 참조

1.신주식의 청약일: 2021년 8월 25일

1.납입기일: 2021년 8월 26일

 

첨부 1) 신주식의 배정방법

–  투자자명(Name): 원익2020R&D 기술혁신투자조합

– 주식수(No of shares): 3,047주

– 총 납입금액(Inv. Amt): 2,000,248,855원

– 주금납일일(Funding date): 2021-08-26

2021년 8월 12일

주식회사 이지엔도서지컬 대표이사 권동수